Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ariela NoyStudy Chair
- David ScaddenStudy ChairKOL profile →
- Parkash GillStudy Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincent'S Hosp / Dept of Haematology
Darlinghurst, Australia
- Alfred Hosp
Prahan, Australia
- Prince of Wales Hosp
Randwick, Australia
- Taylors Square Clinic
Sydney, Australia
- Inst of Tropical Medicine
Antwerp, Belgium
- Chu Saint Pierre
Brussels, Belgium
- Bc Cancer Agency
Vancouver, British Columbia, Canada
- Ottawa General Hospital
Ottawa, Ontario, Canada
- Sunnybrook Health Science Centre
Toronto, Ontario, Canada
- Toronto Gen Hosp
Toronto, Ontario, Canada
- Montreal Gen Hosp / Div of Clin Immuno and Allergy
Montreal, Quebec, Canada
- Aids Healthcare Foundation
Los Angeles, California, United States
- Laglc
Los Angeles, California, United States
- Tower Id Med Associates
Los Angeles, California, United States
- Ucla Care Ctr
Los Angeles, California, United States
- Usc School of Medicine / Norris Cancer Hosp
Los Angeles, California, United States
- Ucsd Med Ctr
San Diego, California, United States
- Conant Med Ctr
San Francisco, California, United States
- Ucsf - San Francisco Gen Hosp
San Francisco, California, United States
- Univ of Miami School of Medicine
Miami, Florida, United States
- Bioquan Research Group
North Miami, Florida, United States
- Grady Mem Hosp
Atlanta, Georgia, United States
- Northwestern Univ
Chicago, Illinois, United States
- Infectious Disease of Indiana
Indianapolis, Indiana, United States
- Johns Hopkins Oncology
Baltimore, Maryland, United States
- Beth Israel Med Ctr
Boston, Massachusetts, United States
- Boston Med Ctr
Boston, Massachusetts, United States
- Massachusetts Gen Hosp
Boston, Massachusetts, United States
- Washington Univ School of Medicine
St Louis, Missouri, United States
- Umdnj - New Jersey Med School
Newark, New Jersey, United States
- Columbia-Presbyterian Hosp
New York, New York, United States
- Mem Sloan - Kettering Cancer Ctr
New York, New York, United States
- New York Univ Med Ctr
New York, New York, United States
- St Vincents Hosp / Clinical Research Program
New York, New York, United States
- Albert Einstein Comprehensive Ctr
The Bronx, New York, United States
- Case Western Reserve Univ
Cleveland, Ohio, United States
- Ohio State Univ
Columbus, Ohio, United States
- Pennsylvania Oncology and Hematology Associates
Philadelphia, Pennsylvania, United States
- Vanderbilt Cancer Ctr
Nashville, Tennessee, United States
- Cytran Inc
Kirkland, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 24 Jun 2005
- Registered enrollment
- 200
- Registry id
- NCT00002445
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.